Photodynamic Therapy Market

Photodynamic Therapy Market (Product Type: Photosensitizer Drugs, and Devices; and Application: Cancer, Dermatological Conditions, Ophthalmology, Gastroenterology, Gynecology, Infectious Disease, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Photodynamic Therapy Market Outlook 2031

  • The global industry was valued at US$ 4.5 Bn in 2022
  • It is projected to grow at a CAGR of 7.9% from 2023 to 2031 and reach more than US$ 8.9 Bn by the end of 2031

Analysts’ Viewpoint

The photodynamic therapy (PDT) market is poised for substantial growth, driven by the increase in number of clinical trials showcasing its effectiveness in treating various medical conditions, particularly cancer.

The surge in minimally invasive surgeries, offering benefits such as reduced pain and shorter hospital stays, further propels market expansion.

Combination therapy, particularly in dermatological treatments, presents lucrative photodynamic therapy market opportunities. PDT is increasingly utilized alongside laser therapy or medications for enhanced efficacy.

Continued advancements in PDT techniques, including targeted drug delivery systems and improved light sources augmenting treatment efficacy and safety is projected to fuel the photodynamic therapy market size.

Hospitals remain key contributors to market expansion, leveraging their comprehensive infrastructure and specialized expertise to meet the growth in patient demand for PDT treatments.

Market Introduction

Photodynamic therapy (PDT) offers a promising approach in medical treatment, utilizing photosensitizer drugs and devices to target and destroy diseased tissues.

Photosensitizer drugs include porphyrin derivatives (PD), aminolevulinic acid (ALA), and chlorines. Devices encompass disposable fiber optic light delivery devices (DFOLDD), diode laser, and lamp-based devices.

Photosensitizer drugs are administered through intravenous, oral, and topical routes. Applications of photodynamic therapy span multiple medical fields, including cancer treatment, dermatological conditions, ophthalmology, gastroenterology, gynecology, and infectious diseases.

With its versatility and efficacy, photodynamic therapy is a valuable tool in medical treatment across diverse healthcare settings. In cancer treatment, PDT targets various types of cancers such as basal cell carcinoma, non-small cell lung cancer, and head & neck cancer.

Dermatological conditions such as psoriasis, acne, and actinic keratosis also benefit from PDT. Additionally, PDT finds application in ophthalmology for age-related macular degeneration and other retinal diseases.

Attribute Detail
Drivers
  • Rise in Number of Clinical Trials
  • Surge in Minimally Invasive Surgeries

Rise in Number of Clinical Trials

The rise in number of molecules undergoing early and late phases of clinical trials is bolstering the photodynamic therapy market growth.

With an increasing number of clinical trials assessing the safety and efficacy of photodynamic therapy (PDT) across different settings and patient populations, there is growing evidence supporting its effectiveness in treating various medical conditions, including cancer.

The approval of these molecules following successful clinical trials present lucrative opportunities for manufacturers to enter and expand their presence in the photodynamic therapy market.

This trend reflects a growing interest and investment in PDT research and development, driving market progress and innovation in the field.

Surge in Minimally Invasive Surgeries Boosting Photodynamic Therapy Market Development

The surge in minimally invasive surgeries is fueled by the increase in demand for cardiac surgeries due to the rise in cardiovascular diseases. Additionally, the growth in emphasis on improving physical appearance has led to a rise in cosmetic surgical procedures, contributing to the demand for minimally invasive interventions.

The prevalence of trauma conditions resulting from road accidents and natural disasters propels the adoption of minimally invasive procedures. Furthermore, the increase in obesity cases has led to a rise in bariatric surgeries aimed at managing weight-related health issues.

The adoption of minimally invasive procedures offers several advantages, such as smaller incisions, reduced pain and scarring, fewer complications, and shorter hospital stays, all of which boosts the photodynamic therapy market value.

Advancements in laser technology including diode lasers facilitating faster recovery, contribute to the growth of the photodynamic therapy market by providing innovative and effective treatment options for various medical conditions, including cancer and dermatological disorders.

Usage of Photodynamic Therapy as Combination Therapy Driving Market Statistics

Research indicates that photodynamic therapy (PDT) is increasingly being employed in combination with laser therapy or medications for enhanced efficacy in treating various skin conditions.

Furthermore, PDT has demonstrated effectiveness in diagnosing and treating malignancies across multiple areas, including lung, esophageal, gastrointestinal, bladder, prostate, head & neck, and oral & skin cancer.

The combination of PDT with other therapies such as metronomic or nanoparticle PDT shows promise in addressing infiltrating growth, a major pathological reason for primary malignant tumors of the bone and soft tissue.

The combination of PDT with electronic magnetic hyperthermia treatment (EMHT) offers several advantages, including the potential to replace conventional tumor surgery and radiotherapy in certain cases.

This highlights the versatility and potential of PDT as a complementary therapy, paving the way for expanded applications and increase in photodynamic therapy market revenue.

Clinical Approvals and Effectiveness of Photosensitizer Drugs

The photodynamic therapy market segmentation by product type includes photosensitizer drugs, and devices. The photosensitizer drugs segment is projected to dominate the market. Photodynamic therapy relies on photosensitizers to absorb light energy, initiating the chemical alteration necessary for treatment.

Moreover, the rise in incidence of bone and soft-tissue malignant tumors and the focus on utilizing photodynamic therapy for the diagnosis and treatment of musculoskeletal sarcoma contribute to the growth of this segment.

While the devices segment is also expanding, advancements in PDT techniques, such as targeted drug delivery systems and improved light sources, further enhance the efficacy and safety of treatment, consolidating the dominance of the photosensitizer drugs segment in the photodynamic therapy market.

High Demand for Intravenous Delivery

As per the photodynamic therapy market analysis, by mode of administration, the intravenous segment is projected to dominate during the forecast period.

Photodynamic therapy (PDT) relies on systemic administration of photosensitizers, often via intravenous injection, allowing for uniform distribution throughout the body and preferential accumulation in diseased tissues.

While PDT can be administered via other routes such as topical or oral, intravenous administration remains a preferred choice for its ability to reach deep-seated lesions and provide systemic therapy and for its versatility and efficacy in delivering therapeutic agents to target sites.

Cancer Treatment Gaining Traction

The photodynamic therapy industry report highlights the dominance of the cancer application segment, ascribed to PDT's effectiveness in targeting and killing cancer cells with minimal invasiveness.

PDT utilizes photosensitizers, often based on a tetrapyrrole structure, to specifically destroy cancerous cells upon exposure to light. This technique, clinically approved and widely utilized, holds promise in treating various cancer types including lung, bladder, gastrointestinal, and gynecological neoplasms.

Regional Outlook of Photodynamic Therapy Industry

Attribute Detail
Leading Region North America

According to the latest photodynamic therapy market forecast, North America, particularly the USA is experiencing steady growth. Substantial investments in healthcare infrastructure, a notable increase in cancer prevalence, regulatory policies & reimbursement scenarios, and ongoing advancements in PDT technology are driving market dynamics in the country.

The USA drives PDT adoption as a viable therapeutic approach across various cancer types such as skin cancer, lung cancer, esophageal cancer, and certain head and neck cancers.

In Asia Pacific, the market is poised for expansion fueled by surge in cancer prevalence, significant demand for PDT, and efforts to strengthen healthcare systems. Increase in awareness of cancer diagnostics and treatment in emerging countries such as India further contributes to market growth by reducing mortality rates and ensuring prompt patient care.

Analysis of Key Players

Leading players in the global photodynamic therapy market have adopted strategies such as development of products and disclosing clinical trial data to increase market trust and share.

The photodynamic therapy market is highly competitive and has a strong presence of key players.

GALDERMA, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., LUMIBIRD Groups (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies Inc., and SUS Advancing Tecchnology CO., Ltd. are the prominent global market manufacturers.

Key Developments

  • On December 1, 2023, Biofrontera AG won a US patent for its Photodynamic Therapy (PDT) treatment protocol, which involves using a photosensitizer and two light exposures at different wavelengths. The patent also safeguards Biofrontera's drug Ameluz® from generic competition, demonstrating the company's commitment to developing new PDT treatment approaches.
  • In January 15, 2024, Theralase Technologies Inc., a pharmaceutical company, reported a Complete Response (CR) of 54% at 6 months, 38% at 12 months, and 37% at 15 months in its Phase II Non-muscle Invasive Bladder Cancer clinical study, exceeding the International Bladder Cancer Group's guidelines.

Each of these players have been profiled in the global photodynamic therapy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Photodynamic Therapy Market Snapshot

Attribute Detail
Market Value in 2022 US$ 4.5 Bn
Forecast (Value) in 2031 US$ 8.9 Bn
Growth Rate (CAGR) 7.9%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product Type
    • Photosensitizer drugs
      • Porphyrin Derivatives
        • Hematoporphyrin Derivative
        • Benzoporphyrin Derivative
        • Texaphyrins
        • Others (Purpurins etc.)
      • Aminolevulic acid
      • Chlorines
      • Others (Phthalocyanine etc.)
    • Devices
      • Disposable Fiber Optic Light Delivery Devices
      • Diode Lasers
      • Lamps
  • Mode of Administration
    • Intravenous
    • Oral
    • Topical
  • Application
    • Cancer
      • Basal Cell Carcinoma
      • Non-small Cell Lung Cancer
      • Head & Neck Cancer
      • Others (Esophagal Cancer etc.)
    • Dermatological Conditions
      • Psoriasis
      • Acne
      • Actinic Keratosis
    • Ophthalmology
      • Age-related Macular degeneration
      • Retinal Disease
    • Gastroenterology
    • Gynecology
    • Infectious Disease
    • Others
  • End-user
    • Hospitals
    • Cosmetics & Dermatology Clinics
    • Cancer Treatment Centers
    • Others (Laser Therapy Centers, Spas and Rejuvenation Centers, etc.)
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • GALDERMA
  • Biofrontera AG
  • Sun Pharmaceuticals Industries Ltd.
  • LUMIBIRD Groups (Quantel Medical)
  • Modulight Corporation
  • Quest PharmaTech, Inc.
  • Theralase Technologies Inc.
  • SUS Advancing Technology Co., Ltd.
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global photodynamic therapy market in 2022?

It was valued at US$ 4.5 Bn in 2022

How big will the photodynamic therapy industry by 2031?

It is projected to reach more than US$ 8.9 Bn by 2031

What will be the CAGR of the photodynamic therapy business during the forecast period?

The CAGR is anticipated to be 7.9% from 2023 to 2031

What are the prominent factors fueling demand for photodynamic therapy?

Continuous advancements in light sources, photosensitizing agents, and delivery systems

Which was the largest photodynamic therapy segment in 2022?

Based on product type, the photosensitizer drugs segment accounted for major share in 2022

Which region is likely to record significant share of the photodynamic therapy landscape during the forecast period?

North America is expected to account for major share during the forecast period

Who are the prominent photodynamic therapy manufacturers?

GALDERMA, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., LUMIBIRD Groups (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies Inc., and SUS Advancing Technology Co., Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Photodynamic Therapy Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Photodynamic Therapy Market Analysis and Forecasts, 2017 - 2031

    5. Key Insights

        5.1. Major Companies in Photodynamic Therapy

        5.2. Key Industry Events

        5.3. Regulatory Scenario by Region/Globally

        5.4. Pipeline Analysis

        5.5. Photosensitizers used in Basic Research for Cancer Treatment

    6. Global Photodynamic Therapy Market Analysis and Forecasts, By Product Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast By Product Type, 2017 - 2031

            6.3.1. Photosensitizer Drugs

                6.3.1.1. Porphyrin Derivatives

                    6.3.1.1.1. Hematoporphyrin Derivative

                    6.3.1.1.2. Benzoporphyrin Derivative

                    6.3.1.1.3. Texaphyrins

                    6.3.1.1.4. Others

                6.3.1.2. Aminolevulic acid

                6.3.1.3. Chlorines

                6.3.1.4. Others

            6.3.2. Devices

                6.3.2.1. Disposable Fiber Optic Light Delivery Devices

                6.3.2.2. Diode Laser

                6.3.2.3. Lamp

        6.4. Market Attractiveness By Product Type

    7. Global Photodynamic Therapy Market Analysis and Forecasts, By Mode of Administration

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast By Mode of Administration, 2017 - 2031

            7.3.1. Intravenous

            7.3.2. Oral

            7.3.3. Topical

        7.4. Market Attractiveness By Mode of Administration

    8. Global Photodynamic Therapy Market Analysis and Forecasts, By Application

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast By Application, 2017 - 2031

            8.3.1. Cancer

                8.3.1.1. Basal Cell Carcinoma

                8.3.1.2. Non-Small Cell Lung Cancer

                8.3.1.3. Head & Neck Cancer

                8.3.1.4. Others

            8.3.2. Dermatological Conditions

                8.3.2.1. Psoriasis

                8.3.2.2. Acne

                8.3.2.3. Actinic Keratosis

            8.3.3. Ophthalmology

                8.3.3.1. Age-Related Macular Degeneration

                8.3.3.2. Retinal Disease

            8.3.4. Gastroenterology

            8.3.5. Gynecology

            8.3.6. Infectious Diseases

            8.3.7. Others

        8.4. Market Attractiveness By Application

    9. Global Photodynamic Therapy Market Analysis and Forecasts, By End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast By End-user , 2017 - 2031

            9.3.1. Hospitals

            9.3.2. Cosmetics & Dermatology Clinics

            9.3.3. Cancer Treatment Centers

            9.3.4. Others

        9.4. Market Attractiveness By End-user

    10. Global Photodynamic Therapy Market Analysis and Forecasts, By Region

        10.1. Key Findings

        10.2. Market Value Forecast By Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness By Country/Region

    11. North America Photodynamic Therapy Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast By Product Type, 2017 - 2031

            11.2.1. Photosensitizer Drugs

                11.2.1.1. Porphyrin Derivatives

                    11.2.1.1.1. Hematoporphyrin Derivative

                    11.2.1.1.2. Benzoporphyrin Derivative

                    11.2.1.1.3. Texaphyrins

                    11.2.1.1.4. Others

                11.2.1.2. Aminolevulic acid

                11.2.1.3. Chlorines

                11.2.1.4. Others

            11.2.2. Devices

                11.2.2.1. Disposable Fiber Optic Light Delivery Devices

                11.2.2.2. Diode Laser

                11.2.2.3. Lamp

        11.3. Market Value Forecast By Mode of Administration, 2017 - 2031

            11.3.1. Intravenous

            11.3.2. Oral

            11.3.3. Topical

        11.4. Market Value Forecast By Application, 2017 - 2031

            11.4.1. Cancer

                11.4.1.1. Basal Cell Carcinoma

                11.4.1.2. Non-Small Cell Lung Cancer

                11.4.1.3. Head & Neck Cancer

                11.4.1.4. Others

            11.4.2. Dermatological Conditions

                11.4.2.1. Psoriasis

                11.4.2.2. Acne

                11.4.2.3. Actinic Keratosis

            11.4.3. Ophthalmology

                11.4.3.1. Age-Related Macular Degeneration

                11.4.3.2. Retinal Disease

            11.4.4. Gastroenterology

            11.4.5. Gynecology

            11.4.6. Infectious Diseases

            11.4.7. Others

        11.5. Market Value Forecast By End-user, 2017 - 2031

            11.5.1. Hospitals

            11.5.2. Cosmetics & Dermatology Clinics

            11.5.3. Cancer Treatment Centers

            11.5.4. Others

        11.6. Market Value Forecast By Country, 2017 - 2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Product Type

            11.7.2. By Mode of Administration

            11.7.3. By Application

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Photodynamic Therapy Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast By Product Type, 2017 - 2031

            12.2.1. Photosensitizer Drugs

                12.2.1.1. Porphyrin Derivatives

                    12.2.1.1.1. Hematoporphyrin Derivative

                    12.2.1.1.2. Benzoporphyrin Derivative

                    12.2.1.1.3. Texaphyrins

                    12.2.1.1.4. Others

                12.2.1.2. Aminolevulic acid

                12.2.1.3. Chlorines

                12.2.1.4. Others

            12.2.2. Devices

                12.2.2.1. Disposable Fiber Optic Light Delivery Devices

                12.2.2.2. Diode Laser

                12.2.2.3. Lamp

        12.3. Market Value Forecast By Mode of Administration, 2017 - 2031

            12.3.1. Intravenous

            12.3.2. Oral

            12.3.3. Topical

        12.4. Market Value Forecast By Application, 2017 - 2031

            12.4.1. Cancer

                12.4.1.1. Basal Cell Carcinoma

                12.4.1.2. Non-Small Cell Lung Cancer

                12.4.1.3. Head & Neck Cancer

                12.4.1.4. Others

            12.4.2. Dermatological Conditions

                12.4.2.1. Psoriasis

                12.4.2.2. Acne

                12.4.2.3. Actinic Keratosis

            12.4.3. Ophthalmology

                12.4.3.1. Age-Related Macular Degeneration

                12.4.3.2. Retinal Disease

            12.4.4. Gastroenterology

            12.4.5. Gynecology

            12.4.6. Infectious Diseases

            12.4.7. Others

        12.5. Market Value Forecast By End-user, 2017 - 2031

            12.5.1. Hospitals

            12.5.2. Cosmetics & Dermatology Clinics

            12.5.3. Cancer Treatment Centers

            12.5.4. Others

        12.6. Market Value Forecast By Country, 2017 - 2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Product Type

            12.7.2. By Mode of Administration

            12.7.3. By Application

            12.7.4. By End-user

            12.7.5. By Country

    13. Asia Pacific Photodynamic Therapy Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast By Product Type, 2017 - 2031

            13.2.1. Photosensitizer Drugs

                13.2.1.1. Porphyrin Derivatives

                    13.2.1.1.1. Hematoporphyrin Derivative

                    13.2.1.1.2. Benzoporphyrin Derivative

                    13.2.1.1.3. Texaphyrins

                    13.2.1.1.4. Others

                13.2.1.2. Aminolevulic acid

                13.2.1.3. Chlorines

                13.2.1.4. Others

            13.2.2. Devices

                13.2.2.1. Disposable Fiber Optic Light Delivery Devices

                13.2.2.2. Diode Laser

                13.2.2.3. Lamp

        13.3. Market Value Forecast By Mode of Administration, 2017 - 2031

            13.3.1. Intravenous

            13.3.2. Oral

            13.3.3. Topical

        13.4. Market Value Forecast By Application, 2017 - 2031

            13.4.1. Cancer

                13.4.1.1. Basal Cell Carcinoma

                13.4.1.2. Non-Small Cell Lung Cancer

                13.4.1.3. Head & Neck Cancer

                13.4.1.4. Others

            13.4.2. Dermatological Conditions

                13.4.2.1. Psoriasis

                13.4.2.2. Acne

                13.4.2.3. Actinic Keratosis

            13.4.3. Ophthalmology

                13.4.3.1. Age-Related Macular Degeneration

                13.4.3.2. Retinal Disease

            13.4.4. Gastroenterology

            13.4.5. Gynecology

            13.4.6. Infectious Diseases

            13.4.7. Others

        13.5. Market Value Forecast By End-user, 2017 - 2031

            13.5.1. Hospitals

            13.5.2. Cosmetics & Dermatology Clinics

            13.5.3. Cancer Treatment Centers

            13.5.4. Others

        13.6. Market Value Forecast By Country, 2017 - 2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Product Type

            13.7.2. By Mode of Administration

            13.7.3. By Application

            13.7.4. By End-user

            13.7.5. By Country

    14. Latin America Photodynamic Therapy Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast By Product Type, 2017 - 2031

            14.2.1. Photosensitizer Drugs

                14.2.1.1. Porphyrin Derivatives

                    14.2.1.1.1. Hematoporphyrin Derivative

                    14.2.1.1.2. Benzoporphyrin Derivative

                    14.2.1.1.3. Texaphyrins

                    14.2.1.1.4. Others

                14.2.1.2. Aminolevulic acid

                14.2.1.3. Chlorines

                14.2.1.4. Others

            14.2.2. Devices

                14.2.2.1. Disposable Fiber Optic Light Delivery Devices

                14.2.2.2. Diode Laser

                14.2.2.3. Lamp

        14.3. Market Value Forecast By Mode of Administration, 2017 - 2031

            14.3.1. Intravenous

            14.3.2. Oral

            14.3.3. Topical

        14.4. Market Value Forecast By Application, 2017 - 2031

            14.4.1. Cancer

                14.4.1.1. Basal Cell Carcinoma

                14.4.1.2. Non-Small Cell Lung Cancer

                14.4.1.3. Head & Neck Cancer

                14.4.1.4. Others

            14.4.2. Dermatological Conditions

                14.4.2.1. Psoriasis

                14.4.2.2. Acne

                14.4.2.3. Actinic Keratosis

            14.4.3. Ophthalmology

                14.4.3.1. Age-Related Macular Degeneration

                14.4.3.2. Retinal Disease

            14.4.4. Gastroenterology

            14.4.5. Gynecology

            14.4.6. Infectious Diseases

            14.4.7. Others

        14.5. Market Value Forecast By End-user, 2017 - 2031

            14.5.1. Hospitals

            14.5.2. Cosmetics & Dermatology Clinics

            14.5.3. Cancer Treatment Centers

            14.5.4. Others

        14.6. Market Value Forecast By Country, 2017 - 2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Product Type

            14.7.2. By Mode of Administration

            14.7.3. By Application

            14.7.4. By End-user

            14.7.5. By Country

    15. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast By Product Type, 2017 - 2031

            15.2.1. Photosensitizer Drugs

                15.2.1.1. Porphyrin Derivatives

                    15.2.1.1.1. Hematoporphyrin Derivative

                    15.2.1.1.2. Benzoporphyrin Derivative

                    15.2.1.1.3. Texaphyrins

                    15.2.1.1.4. Others

                15.2.1.2. Aminolevulic acid

                15.2.1.3. Chlorines

                15.2.1.4. Others

            15.2.2. Devices

                15.2.2.1. Disposable Fiber Optic Light Delivery Devices

                15.2.2.2. Diode Laser

                15.2.2.3. Lamp

        15.3. Market Value Forecast By Mode of Administration, 2017 - 2031

            15.3.1. Intravenous

            15.3.2. Oral

            15.3.3. Topical

        15.4. Market Value Forecast By Application, 2017 - 2031

            15.4.1. Cancer

                15.4.1.1. Basal Cell Carcinoma

                15.4.1.2. Non-Small Cell Lung Cancer

                15.4.1.3. Head & Neck Cancer

                15.4.1.4. Others

            15.4.2. Dermatological Conditions

                15.4.2.1. Psoriasis

                15.4.2.2. Acne

                15.4.2.3. Actinic Keratosis

            15.4.3. Ophthalmology

                15.4.3.1. Age-Related Macular Degeneration

                15.4.3.2. Retinal Disease

            15.4.4. Gastroenterology

            15.4.5. Gynecology

            15.4.6. Infectious Diseases

            15.4.7. Others

        15.5. Market Value Forecast By End-user, 2017 - 2031

            15.5.1. Hospitals

            15.5.2. Cosmetics & Dermatology Clinics

            15.5.3. Cancer Treatment Centers

            15.5.4. Others

        15.6. Market Value Forecast By Country, 2017 - 2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. By Product Type

            15.7.2. By Mode of Administration

            15.7.3. By Application

            15.7.4. By End-user

            15.7.5. By Country

    16. Competition Landscape

        16.1. Global Sanitization Robots Market, Company Share Analysis (2022)

        16.2. Company Profiles

            16.2.1. GALDERMA

                16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.1.2. Product Portfolio

                16.2.1.3. Financial Overview

                16.2.1.4. SWOT Analysis

                16.2.1.5. Strategic Overview

            16.2.2. Biofrontera AG

                16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.2.2. Product Portfolio

                16.2.2.3. Financial Overview

                16.2.2.4. SWOT Analysis

                16.2.2.5. Strategic Overview

            16.2.3. Sun Pharmaceuticals Industries Ltd.

                16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.3.2. Product Portfolio

                16.2.3.3. Financial Overview

                16.2.3.4. SWOT Analysis

                16.2.3.5. Strategic Overview

            16.2.4. LUMIBIRD Groups (Quantel Medical)

                16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.4.2. Product Portfolio

                16.2.4.3. Financial Overview

                16.2.4.4. SWOT Analysis

                16.2.4.5. Strategic Overview

            16.2.5. Modulight Corporation

                16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.5.2. Product Portfolio

                16.2.5.3. Financial Overview

                16.2.5.4. SWOT Analysis

                16.2.5.5. Strategic Overview

            16.2.6. Quest PharmaTech, Inc.

                16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.6.2. Product Portfolio

                16.2.6.3. Financial Overview

                16.2.6.4. SWOT Analysis

                16.2.6.5. Strategic Overview

            16.2.7. Theralase Technologies Inc.

                16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.7.2. Product Portfolio

                16.2.7.3. Financial Overview

                16.2.7.4. SWOT Analysis

                16.2.7.5. Strategic Overview

            16.2.8. SUS Advancing Tecchnology CO., Ltd.

                16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.8.2. Product Portfolio

                16.2.8.3. Financial Overview

                16.2.8.4. SWOT Analysis

                16.2.8.5. Strategic Overview

            16.2.9. Others

                16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.9.2. Product Portfolio

                16.2.9.3. Financial Overview

                16.2.9.4. SWOT Analysis

                16.2.9.5. Strategic Overview

    List of Tables

    Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031

    Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031

    Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031

    Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031

    Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Dermatological Conditions, 2017-2031

    Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Ophthalmology, 2017-2031

    Table 09: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 10: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region, 2017-2031

    Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031

    Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 17: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 18: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 19: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 20: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user , 2017-2031

    Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 25: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031

    Table 26: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 27: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 28: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 29: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 30: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user , 2017-2031

    Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 33: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 34: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 35: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031

    Table 36: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 37: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 38: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 39: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 40: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 41: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 42: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 43: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 44: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 45: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031

    Table 46: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 47: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 48: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 49: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 50: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 51: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 52: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 53: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 54: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

    Table 55: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031

    Table 56: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 57: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 58: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 59: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 60: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017-2031

    Figure 02: Global Photodynamic Therapy Market Value Share, by Product Type, 2022

    Figure 03: Global Photodynamic Therapy Market Value Share, by Application, 2022

    Figure 04: Global Photodynamic Therapy Market Value Share, by Mode of Administration, 2022

    Figure 05: Global Photodynamic Therapy Market Value Share, by End-user , 2022

    Figure 06: Global Photodynamic Therapy Market Value Share, by Region, 2022

    Figure 07: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

    Figure 08: Global Photodynamic Therapy Market Share Analysis, by Product Type, 2022

    Figure 09: Global Photodynamic Therapy Market Share Analysis, by Product Type, 2031

    Figure 10: Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 11: Global Photodynamic Therapy Market Value (US$ Mn), by Photosensitizer Drugs, 2017-2031

    Figure 12: Global Photodynamic Therapy Market Value Share Analysis, by Photosensitizer Drugs, 2022 and 2031

    Figure 13: Global Photodynamic Therapy Market Value (US$ Mn), by Devices, 2017-2031

    Figure 14: Global Photodynamic Therapy Market Value Share Analysis, by Devices, 2022 and 2031

    Figure 15: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031

    Figure 16: Global Photodynamic Therapy Market Share Analysis, by Mode of Administration, 2022

    Figure 17: Global Photodynamic Therapy Market Share Analysis, by Mode of Administration, 2031

    Figure 18: Global Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031

    Figure 19: Global Photodynamic Therapy Market Value (US$ Mn), by Intravenous, 2017-2031

    Figure 20: Global Photodynamic Therapy Market Value Share Analysis, by Intravenous, 2022 and 2031

    Figure 21: Global Photodynamic Therapy Market Value (US$ Mn), by Oral, 2017-2031

    Figure 22: Global Photodynamic Therapy Market Value Share Analysis, by Oral, 2022 and 2031

    Figure 23: Global Photodynamic Therapy Market Value (US$ Mn), by Topical, 2017-2031

    Figure 24: Global Photodynamic Therapy Market Value Share Analysis, by Topical, 2022 and 2031

    Figure 25: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 26: Global Photodynamic Therapy Market Share Analysis, by Application, 2022

    Figure 27: Global Photodynamic Therapy Market Share Analysis, by Application, 2031

    Figure 28: Global Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031

    Figure 29: Global Photodynamic Therapy Market Value (US$ Mn), by Cancer, 2017-2031

    Figure 30: Global Photodynamic Therapy Market Value Share Analysis, by Cancer, 2022 and 2031

    Figure 31: Global Photodynamic Therapy Market Value (US$ Mn), by Dermatological Conditions, 2017-2031

    Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Dermatological Conditions, 2022 and 2031

    Figure 33: Global Photodynamic Therapy Market Value (US$ Mn), by Ophthalmology, 2017-2031

    Figure 34: Global Photodynamic Therapy Market Value Share Analysis, by Ophthalmology, 2022 and 2031

    Figure 35: Global Photodynamic Therapy Market Value (US$ Mn), by Gastroenterology, 2017-2031

    Figure 36: Global Photodynamic Therapy Market Value Share Analysis, by Gastroenterology, 2022 and 2031

    Figure 37: Global Photodynamic Therapy Market Value (US$ Mn), by Gynecology, 2017-2031

    Figure 38: Global Photodynamic Therapy Market Value Share Analysis, by Gynecology, 2022 and 2031

    Figure 39: Global Photodynamic Therapy Market Value (US$ Mn), by Infectious Disease, 2017-2031

    Figure 40: Global Photodynamic Therapy Market Value Share Analysis, by Infectious Disease, 2022 and 2031

    Figure 41: Global Photodynamic Therapy Market Value (US$ Mn), by Others, 2017-2031

    Figure 42: Global Photodynamic Therapy Market Value Share Analysis, by Others, 2022 and 2031

    Figure 43: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031

    Figure 44: Global Photodynamic Therapy Market Share Analysis, by End-user , 2022

    Figure 45: Global Photodynamic Therapy Market Share Analysis, by End-user , 2031

    Figure 46: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031

    Figure 47: Global Photodynamic Therapy Market Value (US$ Mn), by Hospitals, 2017-2031

    Figure 48: Global Photodynamic Therapy Market Value Share Analysis, by Hospitals, 2022 and 2031

    Figure 49: Global Photodynamic Therapy Market Value (US$ Mn), by Cosmetic & Dermatology Clinics, 2017-2031

    Figure 50: Global Photodynamic Therapy Market Value Share Analysis, by Cosmetic & Dermatology Clinics, 2022 and 2031

    Figure 51: Global Photodynamic Therapy Market Value (US$ Mn), by Cancer Treatment Centers, 2017-2031

    Figure 52: Global Photodynamic Therapy Market Value Share Analysis, by Cancer Treatment Centers, 2022 and 2031

    Figure 53: Global Photodynamic Therapy Market Value (US$ Mn), by Others, 2017-2031

    Figure 54: Global Photodynamic Therapy Market Value Share Analysis, by Others, 2022 and 2031

    Figure 55: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2022 and 2031

    Figure 56: Global Photodynamic Therapy Market Share Analysis, by Region, 2022

    Figure 57: Global Photodynamic Therapy Market Share Analysis, by Region, 2031

    Figure 58: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2023-2031

    Figure 59: North America Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 60: North America Photodynamic Therapy Market Value Share Analysis, by Country, 2022 and 2031

    Figure 61: North America Photodynamic Therapy Market Attractiveness Analysis, by Country, 2023-2031

    Figure 62: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

    Figure 63: North America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 64: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031

    Figure 65: North America Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031

    Figure 66: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 67: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031

    Figure 68: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031

    Figure 69: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031

    Figure 70: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 71: Europe Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 72: Europe Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 73: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

    Figure 74: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 75: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031

    Figure 76: Europe Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031

    Figure 77: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 78: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031

    Figure 79: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031

    Figure 80: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031

    Figure 81: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 82: Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 83: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 84: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

    Figure 85: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 86: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031

    Figure 87: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031

    Figure 88: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 89: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031

    Figure 90: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031

    Figure 91: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031

    Figure 92: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 93: Latin America Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 94: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 95: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

    Figure 96: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 97: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031

    Figure 98: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031

    Figure 99: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 100: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031

    Figure 101: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031

    Figure 102: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031

    Figure 103: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 104: Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 105: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 106: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

    Figure 107: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 108: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031

    Figure 109: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031

    Figure 110: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

    Figure 111: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031

    Figure 112: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031

    Figure 113: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved